📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Preclinical to clinical utility of ROCK inhibitors in cancer. (2023)

First Author: Barcelo J

Attributed to: MECHANOMETMOT: Understanding the crosstalk between mechano-sensing and metabolic reprogramming during tumour dissemination funded by Horizon Europe Guarantee

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.trecan.2022.12.001

PubMed Identifier: 36599733

Publication URI: http://europepmc.org/abstract/MED/36599733

Type: Journal Article/Review

Volume: 9

Parent Publication: Trends in cancer

Issue: 3

ISSN: 2405-8025